SurgiSeal

Topical Skin Adhesive

SurgiSeal™Superior Flexibility and Optimal Strength.

SurgiSeal™ topical skin adhesive provides the optimal balance between strength and flexibility. SurgiSeal adhesive can replace sutures for incision or laceration repair and is designed to save time during wound repair, provide a flexible, water-resistant, antimicrobial protective coating, and eliminate the need for suture removal.  

Top Features & Benefits
High-Strength 2-Octyl Cyanoacrylate FormulationSurgiSeal™ adhesive is made with a 2-octyl cyanoacrylate formulation, which features a greater breaking strength and broader uses in clinical applications than existing n-butyl-2-cyanoacrylates.(1)

High Moisture Vapor Transmission Rate (MVTR)The proprietary formulation is designed to provide optimal permeability, increasing moisture and oxygen transmission to the wound.

Antimicrobial Protective CoatingAs a microbial barrier, SurgiSeal adhesive can also be used as an auxiliary adhesive in conjunction with conventional suturing for surgical incision closure, which can reduce postoperative infection rate significantly.(2)

OctylFlex™ TechnologyProvides increased flexibility designed to contribute to patient comfort and helps preserve the integrity of the adhesive, preventing premature sloughing.

Precision ApplicatorThe patented applicator is designed to provide greater coverage with less adhesive material and requires no catalyst to activate its adhesive properties. This self-contained applicator is designed to increase efficiency in the OR, to be used on multiple lacerations, and to reduce waste.

Higher Permeability Promotes faster Healing.(3)Studies demonstrate that adhesives with high Moisture Vapor Transmission Rate (MVTR) contribute to improved wound care, and tests show that SurgiSeal's MVTR is more than twice that of its leading competitor.(4)

1. Schwade, Nathan D. eMedicine. 2007. WebMD. 17 September 2007 .2. Souza EC, Fitaroni RB, Januzelli DM, Macruz HM, Camacho JC, & Souza MR. (2008). Use of 2-octyl cyanoacrylate for skin closure of sternal incisions in cardiac surgery: observations of microbial barrier effects. Current Medical Research and Opinion. 24(1), 151-5.3. Schwade, Nathan D. eMedicine. 2007. WebMD. 17 September 2007 .4. Data on file. Adhezion Biomedical, LLC.